Diamyd Medical (Germany) Buy Hold or Sell Recommendation
| DMN Stock | EUR 1.07 0.01 0.94% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Diamyd Medical AB is 'Strong Sell'. Macroaxis provides Diamyd Medical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding DMN positions.
Check out Diamyd Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Diamyd and provide practical buy, sell, or hold advice based on investors' constraints. Diamyd Medical AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Diamyd |
Execute Diamyd Medical Buy or Sell Advice
The Diamyd recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Diamyd Medical AB. Macroaxis does not own or have any residual interests in Diamyd Medical AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Diamyd Medical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Diamyd Medical Trading Alerts and Improvement Suggestions
| Diamyd Medical AB generated a negative expected return over the last 90 days | |
| Diamyd Medical AB has some characteristics of a very speculative penny stock | |
| Diamyd Medical AB has high historical volatility and very poor performance | |
| Diamyd Medical AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 454 K. Net Loss for the year was (103.52 M) with loss before overhead, payroll, taxes, and interest of (3.95 M). | |
| Diamyd Medical generates negative cash flow from operations | |
| About 35.0% of the company shares are held by company insiders |
Diamyd Medical Returns Distribution Density
The distribution of Diamyd Medical's historical returns is an attempt to chart the uncertainty of Diamyd Medical's future price movements. The chart of the probability distribution of Diamyd Medical daily returns describes the distribution of returns around its average expected value. We use Diamyd Medical AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Diamyd Medical returns is essential to provide solid investment advice for Diamyd Medical.
| Mean Return | -0.25 | Value At Risk | -4.04 | Potential Upside | 5.88 | Standard Deviation | 3.79 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Diamyd Medical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Diamyd Medical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Diamyd Medical or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Diamyd Medical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Diamyd stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.28 | |
β | Beta against Dow Jones | 0.22 | |
σ | Overall volatility | 3.67 | |
Ir | Information ratio | -0.1 |
Diamyd Medical Volatility Alert
Diamyd Medical AB exhibits very low volatility with skewness of 1.11 and kurtosis of 1.7. Diamyd Medical AB is a potential penny stock. Although Diamyd Medical may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Diamyd Medical AB. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Diamyd instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Diamyd Medical Fundamentals Vs Peers
Comparing Diamyd Medical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Diamyd Medical's direct or indirect competition across all of the common fundamentals between Diamyd Medical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Diamyd Medical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Diamyd Medical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Diamyd Medical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Diamyd Medical to competition |
| Fundamentals | Diamyd Medical | Peer Average |
| Return On Equity | -0.42 | -0.31 |
| Return On Asset | -0.25 | -0.14 |
| Current Valuation | 96.81 M | 16.62 B |
| Shares Outstanding | 76.93 M | 571.82 M |
| Shares Owned By Insiders | 35.22 % | 10.09 % |
| Shares Owned By Institutions | 0.26 % | 39.21 % |
| Price To Book | 5.52 X | 9.51 X |
| Price To Sales | 2,594 X | 11.42 X |
| Revenue | 454 K | 9.43 B |
| Gross Profit | (3.95 M) | 27.38 B |
| EBITDA | (98.88 M) | 3.9 B |
| Net Income | (103.52 M) | 570.98 M |
| Current Ratio | 5.83 X | 2.16 X |
| Book Value Per Share | 0.09 X | 1.93 K |
| Cash Flow From Operations | (93.22 M) | 971.22 M |
| Earnings Per Share | (0.11) X | 3.12 X |
| Target Price | 19.0 | |
| Number Of Employees | 20 | 18.84 K |
| Beta | 1.91 | -0.15 |
| Market Capitalization | 99.6 M | 19.03 B |
| Total Asset | 236.52 M | 29.47 B |
| Net Asset | 236.52 M |
Diamyd Medical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Diamyd . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 1.07 | |||
| Day Typical Price | 1.07 | |||
| Price Action Indicator | 0.005 | |||
| Period Momentum Indicator | 0.01 | |||
| Relative Strength Index | 40.44 |
About Diamyd Medical Buy or Sell Advice
When is the right time to buy or sell Diamyd Medical AB? Buying financial instruments such as Diamyd Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Diamyd Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large & Mid Caps ETFs Thematic Idea Now
Large & Mid Caps ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Large & Mid Caps ETFs theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large & Mid Caps ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Diamyd Stock
Diamyd Medical financial ratios help investors to determine whether Diamyd Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diamyd with respect to the benefits of owning Diamyd Medical security.